A study for a 24 year old man who takes Paroxetine, Ritalin (an AI-powered real world drug study)

Summary:

33 males aged 24 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 24 year old male patient who has Anxiety Disorder, Attention Deficit/hyperactivity Disorder. The study is created by eHealthMe based on reports from sources including the FDA.

On Jan, 25, 2026

33 males aged 24 (±5) who take Paroxetine, Ritalin and have adverse effects are studied.

Number of reports submitted per year:

Paroxetine, Ritalin for a 24-year old man.

Information of the patient in this study:

Age: 24
Gender: male

What are the drugs?

Paroxetine has active ingredients of paroxetine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 65,082 Paroxetine users. Check the latest studies of Paroxetine.
Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,423 Ritalin users. Check the latest studies of Ritalin.

What are the conditions?

Anxiety disorder is found to be associated with 1,528 drugs and 1,559 conditions by eHealthMe. Check the latest studies of Anxiety disorder.
Attention deficit/hyperactivity disorder is found to be associated with 1,577 drugs and 1,428 conditions by eHealthMe. Check the latest studies of Attention deficit/hyperactivity disorder.

Common drug interactions *:

Suicidal Ideation : 10 people, 30.30%
Overdose : 7 people, 21.21%
Completed Suicide (act of taking one's own life): 7 people, 21.21%
Drug Dependence : 7 people, 21.21%
Self Mutilation : 6 people, 18.18%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 6 people, 18.18%
Neck Pain : 5 people, 15.15%
Pain In Limb : 5 people, 15.15%
Rebound Effect (take-back effect): 4 people, 12.12%
Stress Symptoms : 4 people, 12.12%
Chest Pain : 3 people, 9.09%
Suicide Attempt : 3 people, 9.09%
Aggression : 3 people, 9.09%
Fatigue (feeling of tiredness): 3 people, 9.09%
Dysthymia (mild chronic depression): 3 people, 9.09%
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 3 people, 9.09%
Disturbance In Attention : 2 people, 6.06%
Nausea (feeling of having an urge to vomit): 2 people, 6.06%
Mood Swings (an extreme or rapid change in mood): 2 people, 6.06%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 2 people, 6.06%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

Sedation : 2 people, 6.06%
High Blood Pressure : 2 people, 6.06%
Bipolar Disorder (mood disorder): 2 people, 6.06%
Psychiatric Symptom : 1 person, 3.03%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 1 person, 3.03%
Insomnia (sleeplessness): 1 person, 3.03%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 3.03%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

Drug effectiveness *:

Paroxetine:

n/a

Ritalin:

n/a

* Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Paroxetine: 65,082 reports
Ritalin: 29,423 reports

Treatments, associated medications and conditions:

Anxiety disorder: 31,248 reports
Attention deficit/hyperactivity disorder: 120,287 reports

Drug interactions:

Paroxetine and Ritalin drug interaction (148 reports)

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.